eMedicine Specialties > Pediatrics: General Medicine > Infectious Disease

Human Metapneumovirus

Author: Joseph Domachowske, MD, Professor of Pediatrics, Microbiology and Immunology, Department of Pediatrics, Division of Infectious Diseases, State University of New York-Upstate Medical University
Contributor Information and Disclosures

Updated: May 19, 2009

Introduction

Background

Human metapneumovirus (hMPV) is a respiratory viral pathogen that causes a spectrum of illnesses that range from asymptomatic infection to severe bronchiolitis. In 2001, van den Hoogen et al described the identification of this new human viral pathogen from respiratory samples submitted for viral culture during the winter season.1 Half of the initial 28 human metapneumovirus isolates were cultured from patients younger than 1 year, and 96% were isolated from children younger than 6 years.

Seroprevalence studies revealed that 25% of all children aged 6-12 months who were tested in the Netherlands had detectable antibodies to human metapneumovirus; by age 5 years, 100% of patients showed evidence of past infection. Separate reports from all areas of the world support the early contention that this newly discovered virus is ubiquitous, and, like human respiratory syncytial virus (RSV) infection, is seasonal in nature. 

Although the description of this viral pathogen was first described in children, subsequent reports have highlighted the importance of human metapneumovirus as a cause of respiratory illness in adults of all ages,2,3 in patients with cancer,4 in the elderly population (as a cause of serious lower respiratory tract infection),5 and in adults with underlying chronic medical conditions.6

Pathophysiology

The pathophysiology of human metapneumovirus infection is thought to be closely related to the other common human pneumovirus, RSV. Like RSV, human metapneumovirus has a tropism for the respiratory epithelium. The patient may be asymptomatic, or symptoms may range from mild upper respiratory tract symptoms to severe bronchiolitis and pneumonia. More than 20% of infants with bronchiolitis have been found to be infected with two or more respiratory pathogens at the same time. Of these, more than 10% have been described to be co-infected with human metapneumovirus.7,8  Viremia from human metapneumovirus infection has not yet been demonstrated, but a 2005 reported case of human metapneumovirus encephalitis with concurrent lung disease supports the possibility that the virus may (rarely) enter the bloodstream.

Frequency

United States

Human metapneumovirus infection is very common. Estimates suggest that this virus is the causative agent of infant bronchiolitis in 5-15% of cases. Children infected with respiratory viruses, such as human metapneumovirus, are frequently co-infected with other common respiratory viruses.7,8

International

Seroprevalence studies revealed that 25% of all children aged 6-12 months who were tested in the Netherlands had detectable antibodies to human metapneumovirus; by age 5 years, 100% of patients showed evidence of past infection. In Australia, 3 of 200 (1.5%) randomly chosen respiratory samples with negative results for the presence of known respiratory pathogens had positive results for human metapneumovirus on culture, polymerase chain reaction, or both.

Race

To date, no racial predilection has been described.

Sex

Females accounted for 31% of the patients originally described to have human metapneumovirus infection.

Age

Human metapneumovirus infection is prevalent during infancy and early childhood. By age 5 years, seroprevalence data suggest infection in all (or nearly all) individuals. Available demographic data are limited to the Netherlands, where the virus was originally identified in 2001. Further epidemiologic investigation is needed to determine prevalence in other areas of the world. The role of human metapneumovirus in causing respiratory illness in adults has been explored in detail, highlighting the potential severity of human metapneumovirus infection in elderly patients.5

Clinical

History

Patient history in suspected cases of human metapneumovirus (hMPV) should focus on respiratory symptoms, such as rhinorrhea, congestion, cough, dyspnea, and tachypnea.

Physical

A complete physical examination may reveal rhinorrhea, congestion, cough, tachypnea, wheezing, or rales. A high fever with myalgias has been described in some patients. Respiratory failure may ensue, requiring mechanical ventilation.

Causes

The respiratory viral pathogen human metapneumovirus causes a spectrum of illnesses, which range from asymptomatic infection to severe bronchiolitis. Human respiratory syncytial virus (RSV), parainfluenza virus type 1, human metapneumovirus, and human parainfluenza virus type 3 are all known to cause clinical bronchiolitis. Although RSV has been reported to cause as many as 90% of bronchiolitis cases in infants, the relative contribution of human metapneumovirus remains undetermined.

Human metapneumovirus is a negative-sense nonsegmented RNA virus that has been categorized in the pneumovirus subfamily, family Paramyxoviridae, based on genomic sequence and gene constellation.

Phylogenetic tree showing sequence analysis of hu...

Phylogenetic tree showing sequence analysis of human metapneumovirus (HMPV).

Phylogenetic tree showing sequence analysis of hu...

Phylogenetic tree showing sequence analysis of human metapneumovirus (HMPV).

More on Human Metapneumovirus

Overview: Human Metapneumovirus
Differential Diagnoses & Workup: Human Metapneumovirus
Treatment & Medication: Human Metapneumovirus
Follow-up: Human Metapneumovirus
Multimedia: Human Metapneumovirus
References

References

  1. van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. Jun 2001;7(6):719-24. [Medline].

  2. Walsh EE, Peterson DR, Falsey AR. Human metapneumovirus infections in adults: another piece of the puzzle. Arch Intern Med. Dec 8 2008;168(22):2489-96. [Medline].

  3. Garbino J, Soccal PM, Aubert JD, Rochat T, Meylan P, Thomas Y. Respiratory viruses in bronchoalveolar lavage: a hospital-based cohort study in adults. Thorax. Jan 27 2009;[Medline].

  4. Kamboj M, Gerbin M, Huang CK, Brennan C, Stiles J, Balashov S. Clinical characterization of human metapneumovirus infection among patients with cancer. J Infect. Dec 2008;57(6):464-71. [Medline].

  5. Falsey AR, Dallal GE, Formica MA, Andolina GG, Hamer DH, Leka LL. Long-term care facilities: a cornucopia of viral pathogens. J Am Geriatr Soc. Jul 2008;56(7):1281-5. [Medline].

  6. Falsey AR. Human metapneumovirus infection in adults. Pediatr Infect Dis J. Oct 2008;27(10 Suppl):S80-3. [Medline].

  7. Stempel HE, Martin ET, Kuypers J, Englund JA, Zerr DM. Multiple viral respiratory pathogens in children with bronchiolitis. Acta Paediatr. Jan 2009;98(1):123-6. [Medline].

  8. Paranhos-Baccala G, Komurian-Pradel F, Richard N, Vernet G, Lina B, Floret D. Mixed respiratory virus infections. J Clin Virol. Dec 2008;43(4):407-10. [Medline].

  9. Spyridaki IS, Christodoulou I, de Beer L, Hovland V, Kurowski M, Olszewska-Ziaber A. Comparison of four nasal sampling methods for the detection of viral pathogens by RT-PCR-A GA(2)LEN project. J Virol Methods. Mar 2009;156(1-2):102-6. [Medline].

  10. [Guideline] Bronchiolitis in children. A national clinical guideline. Scottish Intercollegiate Guidelines Network (SIGN). Nov 2006;[Full Text].

  11. [Best Evidence] Doan QH, Kissoon N, Dobson S, et al. A randomized, controlled trial of the impact of early and rapid diagnosis of viral infections in children brought to an emergency department with febrile respiratory tract illnesses. J Pediatr. Jan 2009;154(1):91-5. [Medline].

  12. Hamelin ME, Boivin G. Development and validation of an enzyme-linked immunosorbant assay for human metapneumovirus serology based on recombinant viral protein. Clin Diag Lab Immunol. 2005;12:249-53. [Medline].

  13. Kuypers J, Wright N, Corey L, Morrow R. Detection and quantification of human metapneumovirus in pediatric specimens by real-time RT-PCR. J Clin Virol. 2005;33:299-305. [Medline].

  14. Nissen MD, Siebert DJ, Mackay IM, Sloots TP, Withers SJ. Evidence of human metapneumovirus in Australian children. Med J Aust. Feb 18 2002;176(4):188. [Medline].

  15. Percivalle E, Sarasini A, Visai L, Revello MG, Gerna G. Rapid detection of human metapneumovirus strains in nasopharyngeal aspirates and shell vial cultures by monoclonal antibodies. J Clin Microbiol. Jul 2005;43(7):3443-6. [Medline][Full Text].

  16. Robinson JL, Lee BE, Bastien N, Li Y. Seasonality and clinical features of human metapneumovirus infection in children in Northern Alberta. J Med Virol. 2005;76:98-105. [Medline].

  17. Schildgen O, Glatzel T, Geikowski T, et al. Human metapneumovirus RNA in encephalitis patient. Emerg Infect Dis. Mar 2005;11(3):467-70. [Medline].

  18. Suzuki A, Watanabe O, Okamoto M, et al. Detection of human metapneumovirus from children with acute otitis media. Pediatric Infectious Disease Journal. 2005;24:655-7. [Medline].

  19. Tu CC, Chen LK, Lee YS, Ko CF, Chen CM, Yang HH. An outbreak of human metapneumovirus infection in hospitalized psychiatric adult patients in Taiwan. Scand J Infect Dis. Mar 23 2009;1-5. [Medline].

  20. Williams JV, Martino R, Rabella N, et al. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. Journal of Infectious Diseases. 2005;192:1061-5. [Medline].

Further Reading

Keywords

human metapneumovirus, hMPV, common cold, bronchiolitis, respiratory failure, respiratory tract infection, respiratory syncytial virus, rhinorrhea, congestion, cough, dyspnea, tachypnea, wheezing, rales, RSV, human respiratory syncytial virus, human pneumovirus, encephalitis, treatment, diagnosis

Contributor Information and Disclosures

Author

Joseph Domachowske, MD, Professor of Pediatrics, Microbiology and Immunology, Department of Pediatrics, Division of Infectious Diseases, State University of New York-Upstate Medical University
Joseph Domachowske, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Medical Editor

Itzhak Brook, MD, MSc, Professor, Department of Pediatrics, Georgetown University School of Medicine
Itzhak Brook, MD, MSc is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, Armed Forces Infectious Diseases Society, Association of Military Surgeons of the US, Infectious Diseases Society of America, International Immunocompromised Host Society, International Society for Infectious Diseases, Medical Society of the District of Columbia, New York Academy of Sciences, Pediatric Infectious Diseases Society, Society for Ear, Nose and Throat Advances in Children, Society for Experimental Biology and Medicine, Society for Pediatric Research, Southern Medical Association, and Surgical Infection Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Leslie L Barton, MD, Professor, Program Director, Department of Pediatrics, University of Arizona School of Medicine
Leslie L Barton, MD is a member of the following medical societies: American Academy of Pediatrics, Association of Pediatric Program Directors, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society
Disclosure: Nothing to disclose.

CME Editor

Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine
Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine
Disclosure: Baxter Honoraria Consulting

Chief Editor

Russell W Steele, MD, Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine
Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association
Disclosure: None None None

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.